Forward is all about proactive versus reactive healthcare and at the center of it is founder and CEO Adrian Aoun. He joins Alyssa Julya Smith at Forward's Los Angeles location to talk about some of the benefits of Forward and how technology is being used to help with preventative healthcare. He explains that Tesla's and iPhone's can predict when they're likely to break down and intervene to fix things before it happens and that should be the same with healthcare. Forward created personalized health plans through an in-depth understanding of a person's genetics, blood test results, biomarkers and daily lifestyle. Aoun also explains that Forward doesn't use insurance, but is based on a monthly membership cost that allows Forward to do full diagnostic tests without hidden fees or bills from blood work or other lab testing, explaining that it's all done in the office.

Share:
More In Business
AT&T, Verizon Delay 5G Rollout Near Airports, Runways
Telecom giants AT&T and Verizon have agreed to delay activating their 5G services around airports and runways once again. This comes after major U.S. airlines voiced their concern over the rollout of 5G technology, warning of an impending "catastrophic" aviation crisis. Peter Andersen, Chief Investment Officer, Anderson Capital Management joined Cheddar's Opening Bell to discuss.
Earnings Season Kicks Into High Gear
Earnings season kicks into high gear this week as big players are on tap to report their Q4 numbers. Goldman Sachs, Procter & Gamble, United Airlines, and Netflix are just a few of the companies we're keeping a close eye on to give us a better idea of how they're dealing with the Omicron variant, inflation and interest rates. David Nelson, chief strategist at Belpointe, gives a preview of what to expect.
Inflation Among Biggest Concern for CEOs in 2022
Concerns over inflation have become one of the biggest worries for executives. A survey from The Conference Board shows that more than 900 CEOs consider inflation a top tier concern, a major shift from last year's survey that had it as a low-level concern. Rebecca Ray, Executive Vice President, Human Capital, The Conference Board joined Cheddar's Opening Bell for more.
Investing in mRNA Technologies
David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.
Predicting Major Market Trends for 2022
Thomas Hayes, Chairman at Great Hill Capital, joined Wake Up With Cheddar to break down what to look for on the economic front in the coming months amid an Omicron surge and planned interest rate hikes.
Load More